Introduction
============

Membrane-associated prostaglandin E synthase (mPGES) is a recently identified terminal enzyme of arachidonic acid cascade that catalyzes prostaglandin (PG)H~2~to PGE~2~. We recently reported that expression of mPGES in rheumatoid synovial fibroblasts (RSF) was upregulated by IL-1β, and that the time-course of its expression was delayed and prolonged when compared with that of cyclooxygenase-2 (COX-2).

Objective
=========

To identify the regulating factors of mPGES expression in RSF.

Methods
=======

RSF from patients with rheumatoid arthritis (RA) on surgery, who gave written consent to the use of tissues for this research, were treated with IL-1β, rofecoxib, NS-398, and meloxicam (selective COX-2 inhibitors). The effects of PGE~2~and selective EP1, EP2, EP3, and EP4 receptor agonists (DI-004, AE1-259-01, AE-243, and AE1-329, respectively; Ono Pharmaceutical Co., Osaka, Japan) were also studied in various conditions. Expression of the mRNA and protein of mPGES and COX-2 were analyzed by northern and Western blot analyses, respectively. Expression of PGE~2~receptor mRNA in RSF was determined by RT-PCR. PGE~2~and cAMP production was measured by an ELISA.

Results
=======

Enhanced expression of mPGES mRNA and protein in IL-1β-stimulated RSF was attenuated by rofecoxib, NS-398, or meloxicam. This attenuation was restored by addition of PGE~2~. Exogenous PGE~2~only (without IL-1β stimulation) did not induce expression of mPGES in RSF, indicating that PGE~2~was an enhancer of mPGES expression in the IL-1β-stimulated condition.

We then examined which PGE~2~receptor was important in the enhancing action of PGE~2~in RSF. EP2 and EP4 receptor mRNA was detected in RSF; however, EP1 and EP3 were negative. Addition of AE1-259-01 (EP2 agonist) or AE1-329 (EP4 agonist) as well as PGE~2~restored the inhibitory effects of mPGES expression by rofecoxib. In addition, the restoration by PGE~2~was mimicked by forskolin, a direct activator of adenylate cyclase. Intracellular cAMP was increased by IL-1β and it was inhibited by rofecoxib.

Conclusions
===========

The enhancing property of PGE~2~via EP2/EP4 receptors on mPGES expression may play an important role in the cytokine-stimulated articular inflammation in RA patients. It also seems that COX-2 inhibitors effectively decrease PGE~2~production not only by COX-2 inhibition, but also by reduction of mPGES expression.
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